BioSpace News Archive

The global cardiac surgical devices market was estimated at US$ 2.2 billion in 2020, and is projected to reach US$ 3.1 billion by 2030, growing at a CAGR of 3.3% from 2021 to 2030.

According to QY Research Medical, the global biosurgery market size is projected to reach around US$ 27,324.80 million by 2030 and it is growing at a CAGR of 9.5% from 2021 to 2030.

According to QY Research Medical, the contraceptives market size was estimated at US$ 26,321.5 million in 2020 and it is projected to surpass US$ 50,595.8 million by 2030, growing at a CAGR of 6.8% from 2020 to 2030.

The global renal denervation market size was valued at $156,327.4 thousand in 2020, and is projected to reach $4,555,983.0 thousand by 2030, growing at a CAGR of 40.9% from 2021 to 2030.

According to QY Research Medical, the in vitro toxicity testing market size is projected to hit $59,147.6 million by 2030, growing at a CAGR of 12.2% from 2020 to 2030.

The global pharmaceutical glycerine market size was estimated at $89.89 million in 2020, and it is projected to hit around $246.48 million by 2030, growing at a CAGR of 11.2% from 2021 to 2030.

The global transdermal drug delivery systems market size was accounted US$ 52,476.50 million in 2020, and is projected to garner US$ 87,322.40 million by 2030, growing at a CAGR of 5% from 2021 to 2030.

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf” or the “Company”), a federally regulated manufacturer and distributor of cannabis vapes and oils, announced today the Jamaica Intellectual Property Office has granted Nextleaf a patent for the Company’s foundational process for producing high-purity CBD and THC ingredients.

This is supposed to increase the need to study and ensure the safety of targeted and specific therapies, circumvent probable shortcomings, and evaluate their outcomes.

Arcutis Biotherapeutics, Inc. announced results of a nationwide survey of adults with seborrheic dermatitis and the healthcare providers that treat them, designed to better understand their satisfaction and experience with currently available treatment options.